LPAR1 and diabetic kidney disease: Since Ki16425 and BMS002 are antagonists of the LPA1 receptor and the LPA3 receptor, another study used the LPAR1-specific antagonist AM095 to research the function of the LPAR1 in diabetic nephropathy.